What are you searching for?

Sign in
Online Exclusives

By the Numbers Look at The Top 10 Pharmaceutical Companies

A preview to Contract Pharma's Guide to the Top 20 Pharma and Biopharma companies.

By: Kristin Brooks

Managing Editor, Contract Pharma

A preview to Contract Pharma’s Guide to the Top 20 Pharma and Biopharma Companies, the following is a list of the top 10 Pharma and Biopharma companies by Pharmaceutical sales in U.S. Millions. (excludes consumer healthcare, medical device, diagnostics division sales)

Contract Pharma’s annual guide to the 20 biggest Pharma and Biopharma players highlights key financials, top selling drugs, acquisitions & alliances, drug approvals, pipeline advances, executive moves, and more. Coming soon, Contract Pharma’s July/August Top 20 Companies Report!

1. Roche: $69,753  
2. Merck: $60,115 
3. Pfizer: $58,486  
4. Johnson & Johnson: $54,759  
5. Abbvie: $54,318
6. Sanofi: $47,534  
7. AstraZeneca: $45,811 
8. Novartis $45,440  
9. Bristol Myers Squibb: $45,006   
10. GlaxoSmithKline: $38,609   

Headcount: 103,605
Revenues: $69,753 (-7%)
Pharma Revenues: $54,978 (-2%)
Net Income: $14,681 (-9%)
R&D: $15,725 (flat)
 
Headcount: 72,000
Revenues: $60,115 (+1%)
Net Income: $365 (-97%) 
R&D expenses: $30,531 (+126%)
 
Headcount:~88,000
Revenues: $58,486 billion (-42%) 
Net Income: $2,119 billion (-93%)
R&D expenses: $10,679 (-7%) 
 
Headcount: 130,000
Revenues: $85,159 (+6.5%)
Pharma Revenues: $54,759 (+4%)
Net Income: $13,326 (-19%) 
R&D expenses: $15,085 (+7%)
 
Headcount: ~50,000
Revenues: $54,318 (-6%)
Net Income: $4,873 (-59%)
R&D expenses: $7,675 (+18%)
 
Headcount: 91,000 
Revenues: $47,534 (flat)
Net Income: $5,960 (-36%)  
R&D expenses: $7,425 (flat)
 
Headcount: 89,900
Revenues: $45,811 (+3%)
Net Income: $5,061 (+81%)  
R&D expenses: $10,935 (+12%)
 
Headcount: 78,000
Revenues: $45,440 (+8) 
Net Income: $8,572 (+42%) 
R&D expenses: $11,371 (+24%) 
 
Headcount: 34,100
Revenues: $45,006 (-2%)
Net Income: $8,040 million (+27%)
R&D expenses: $9,299 (-2%)
 
Headcount: 70,000  
Revenues: $38,609 (+3%)
Net Income: $8,587 (+5%) 
R&D expenses: $7,922 (+13%)
 
 

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters